KIMS Hospital in Bhubaneswar has become the first healthcare institution in India to introduce the advanced Aplio i800 Endoscopic Ultrasound (EUS) system, a next-generation platform blending endoscopy and high-resolution ultrasound for superior visualization of gastrointestinal and pancreatic structures.
Glimpse:
Developed through Japanese technology collaboration (Canon Medical and Olympus), the Aplio i800 EUS enables exceptional clarity for early detection of cancers, precise biopsies, and combined diagnosis-treatment in one procedure. KIMS organized a national hands-on workshop to showcase its capabilities, training leading gastroenterologists and underscoring the hospital’s commitment to accessible cutting-edge care under founder Prof. Dr. Achyuta Samanta.
KIMS Hospital Bhubaneswar has marked a significant milestone by deploying the Aplio i800 EUS the country’s inaugural installation of this state-of-the-art endoscopic ultrasonography system. This advanced platform integrates high-resolution ultrasound with endoscopy, delivering unparalleled imaging of internal organs, particularly in the gastrointestinal tract and pancreas.
The Aplio i800 EUS excels in early malignancy detection, guiding fine-needle biopsies, and facilitating single-session diagnosis and intervention reducing patient burden and improving outcomes for complex hepatobiliary-pancreatic conditions. Globally recognized for deeper penetration, high-resolution clarity, and features like Shear Wave Elastography (for tissue stiffness mapping), it represents a leap in minimally invasive diagnostics.
To highlight the technology, KIMS’s Department of Gastroenterology hosted a national-level hands-on workshop, featuring live procedures and expert sessions. Attended by top doctors from across India and Odisha, the event focused on practical training and successful trials.
This introduction aligns with KIMS founder’s vision, Prof. Dr. Achyuta Samanta, to bridge global standards with local accessibility making sophisticated tools available for timely interventions in gastrointestinal and pancreatic cancers.
“This new technology will allow doctors across India to learn its use and successful applications through hands-on training.”
By
HB Team

